Investment
Features
FeesSafety
Academy
More
Pluang+

Stepan Company rebounds with strong margin and sales growth, targeting 11.2% upside by 2028.

Analyst Insights
28 Sep 2026
Seeking Alpha
View Source
Bullish
Stepan Company rebounds with strong margin and sales growth, targeting 11.2% upside by 2028.

Stepan Company is regaining momentum after a challenging start to the year, driven by strong margin recovery and robust growth in volume and pricing across its core segments. The company's pass-through mechanisms and Project Catalyst cost savings have significantly improved EBIT and net income despite volatile feedstock costs. North American sales, especially in surfactants and polymers used in data center construction, are growing faster than global markets, expanding Stepan's market share. The company is rated a Buy with an expected 11.2% upside by 2028, supported by sustainable dividends, attractive valuation, and effective cost and growth strategies.

Stepan Company is the subject of this update, with Pluang providing a snapshot of the Basic Materials sector as of Sep 29, 2026 00:02 WIB. Out of 38 priced US stocks in this sector, only 6 rose while 32 fell. Notably, Barrick Gold Corp (B) declined 4.01% to USD 41.16 with a typical hold time of 54 days, Kinross Gold Corporation (KGC) dropped 3.71% to USD 24.12 with a 52-day hold, and Albemarle Corp. (ALB) fell 2.77% to USD 106.69 with a 50-day hold time, illustrating a broadly negative day for the sector.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
2 hours ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
3 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
3 hours ago
Ethereum (ETH) price dips below $2,700 on Binance, signaling a key support break.

Ethereum (ETH) price dips below $2,700 on Binance, signaling a key support break.

Ethereum's price fell below the critical $2,700 level on Binance spot trading, reaching $2,696 as of 9:37 a.m. ET on September 28. This break is notable because $2,700 is a closely watched support level by traders. Despite this drop, ETH's price was ...

Market News
Bearish
4 hours ago
World Assets, Ltd. completes $49M in locked OTC token sales over the past month

World Assets, Ltd. completes $49M in locked OTC token sales over the past month

World Assets, Ltd. has completed multiple over-the-counter (OTC) sales totaling $49 million in the past month, involving their token WLD. Each transaction is subject to a one-year lockup period, meaning the tokens cannot be sold or transferred during...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App